These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18704769)

  • 1. P2X7 receptors in oligodendrocytes: a novel target for neuroprotection.
    Matute C
    Mol Neurobiol; 2008 Oct; 38(2):123-8. PubMed ID: 18704769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptors mediate ischemic damage to oligodendrocytes.
    Domercq M; Perez-Samartin A; Aparicio D; Alberdi E; Pampliega O; Matute C
    Glia; 2010 Apr; 58(6):730-40. PubMed ID: 20029962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 receptor interaction and signalling cascades in neuroprotection.
    Miras-Portugal MT; Queipo MJ; Gil-Redondo JC; Ortega F; Gómez-Villafuertes R; Gualix J; Delicado EG; Pérez-Sen R
    Brain Res Bull; 2019 Sep; 151():74-83. PubMed ID: 30593879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
    Fumagalli M; Lecca D; Abbracchio MP
    Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase.
    Panenka W; Jijon H; Herx LM; Armstrong JN; Feighan D; Wei T; Yong VW; Ransohoff RM; MacVicar BA
    J Neurosci; 2001 Sep; 21(18):7135-42. PubMed ID: 11549724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis.
    Matute C; Torre I; Pérez-Cerdá F; Pérez-Samartín A; Alberdi E; Etxebarria E; Arranz AM; Ravid R; Rodríguez-Antigüedad A; Sánchez-Gómez M; Domercq M
    J Neurosci; 2007 Aug; 27(35):9525-33. PubMed ID: 17728465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y
    Shen D; Shen X; Schwarz W; Grygorczyk R; Wang L
    Exp Dermatol; 2020 May; 29(5):499-508. PubMed ID: 32155290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X7 receptors in the central nervous system.
    Miras-Portugal MT; Ortega F; Gómez-Villafuertes R; Gualix J; Pérez-Sen R; Delicado EG
    Biochem Pharmacol; 2021 May; 187():114472. PubMed ID: 33587917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential crosstalk between P2X7 and arachidonic acid in activation of mitogen-activated protein kinases.
    Barbieri R; Alloisio S; Ferroni S; Nobile M
    Neurochem Int; 2008 Dec; 53(6-8):255-62. PubMed ID: 18804898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate and ATP signalling in white matter pathology.
    Matute C
    J Anat; 2011 Jul; 219(1):53-64. PubMed ID: 21250988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia.
    Suzuki T; Hide I; Ido K; Kohsaka S; Inoue K; Nakata Y
    J Neurosci; 2004 Jan; 24(1):1-7. PubMed ID: 14715932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
    Hu Y; Fisette PL; Denlinger LC; Guadarrama AG; Sommer JA; Proctor RA; Bertics PJ
    J Biol Chem; 1998 Oct; 273(42):27170-5. PubMed ID: 9765236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling of two pools of P2X7 receptors to distinct intracellular signaling pathways in rat submandibular gland.
    Garcia-Marcos M; Pérez-Andrés E; Tandel S; Fontanils U; Kumps A; Kabré E; Gómez-Muñoz A; Marino A; Dehaye JP; Pochet S
    J Lipid Res; 2006 Apr; 47(4):705-14. PubMed ID: 16415476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human P2Y
    Dreisig K; Sund L; Dommer MW; Kristensen NP; Boddum K; Viste R; Fredholm S; Odum N; Jäättelä M; Skov S; Kornum BR
    Front Immunol; 2018; 9():1159. PubMed ID: 29937766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1/2 activation is involved in the neuroprotective action of P2Y13 and P2X7 receptors against glutamate excitotoxicity in cerebellar granule neurons.
    Ortega F; Pérez-Sen R; Delicado EG; Teresa Miras-Portugal M
    Neuropharmacology; 2011 Dec; 61(8):1210-21. PubMed ID: 21798274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors.
    Sperlágh B; Haskó G; Németh Z; Vizi ES
    Neurochem Int; 1998 Sep; 33(3):209-15. PubMed ID: 9759915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large pore formation uniquely associated with P2X7 purinergic receptor channels. Focus on "Are second messengers crucial for opening the pore associated with P2X7 receptor?".
    Liang L; Schwiebert EM
    Am J Physiol Cell Physiol; 2005 Feb; 288(2):C240-2. PubMed ID: 15643049
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation.
    del Puerto A; Díaz-Hernández JI; Tapia M; Gomez-Villafuertes R; Benitez MJ; Zhang J; Miras-Portugal MT; Wandosell F; Díaz-Hernández M; Garrido JJ
    J Cell Sci; 2012 Jan; 125(Pt 1):176-88. PubMed ID: 22250198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.